Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

BACKGROUND: Artemisinin-based combination therapy (ACT) is the first-line anti-malarial treatment of uncomplicated malaria in most malaria endemic countries, including Tanzania. Unfortunately, there have been reports of artemisinin resistance and ACT failure from South East Asia highlighting the nee...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Malar J
Hlavní autoři: Kakolwa, Mwaka A., Mahende, Muhidin K., Ishengoma, Deus S., Mandara, Celine I., Ngasala, Billy, Kamugisha, Erasmus, Kataraihya, Johannes B., Mandike, Renata, Mkude, Sigsbert, Chacky, Frank, Njau, Ritha, Premji, Zul, Lemnge, Martha M., Warsame, Marian, Menard, Didier, Kabanywanyi, Abdunoor M.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192314/
https://ncbi.nlm.nih.gov/pubmed/30333022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-018-2524-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky